Pharmaceutical Business Review - EntreMed has revealed that an an independent Data Safety Monitoring Board has conducted a favorable review of safety data from its breast cancer drug. The review was undertaken to assess the safety of the drug, MKC-1 in a phase II trial in patients
Online Press Release
PRWeb - Mesothelioma Advice Website is Launched - Mesothelioma Advice aims to provide vital information and raise awareness of InfoValue Announces QuickVideo Probe Video Multicast Diagnosis Tool InfoValue Computing, Inc. ( InfoValue ), experts
Page 1 || Page 2 || Page 3 || Page 4 || Page 5
Times Online - Eventually emerging as the epicentre of the “blue curse”, its ex-workers those that are still alive are now known to have a 16% risk of disease; and time from mesothelioma diagnosis to death is around six months. In 1978, back when asbestos